💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Ex-Theranos CEO Holmes puts mental state at issue, to be examined by U.S. experts

Published 09/10/2020, 12:02 PM
Updated 09/10/2020, 12:30 PM
© Reuters. FILE PHOTO: Former Theranos CEO Elizabeth Holmes arrives for a hearing at a federal court in San Jose

By Jonathan Stempel

(Reuters) - A federal judge ordered former Theranos Inc Chief Executive Elizabeth Holmes to be examined by U.S. government experts, after lawyers defending her against criminal fraud charges said they may offer evidence she suffered from a mental disease or defect.

In a decision late Wednesday, U.S. District Judge Edward Davila in San Jose, California overruled defense objections to letting a psychologist and psychiatrist chosen by the government examine the 36-year-old Holmes for 14 hours over two days, and having the examinations recorded on video.

Davila authorized the examinations after Holmes' lawyers said they intended to introduce expert evidence from a clinical psychologist "relating to a mental disease or defect or any other mental condition of the defendant bearing on the issue of guilt."

The defense expert, Mindy Mechanic, is a California State University at Fullerton professor specializing in psychosocial consequences of violence, trauma and victimization, including violence against women, and often testifies in cases involving interpersonal violence, according to her university biography.

Lawyers for Holmes did not immediately respond on Thursday to requests for comment. The professor did not immediately respond to a similar request.

Wednesday's decision was partially redacted. Holmes' mental state had been previously discussed in sealed court documents and a closed July 8 hearing.

Holmes and former Theranos President Ramesh "Sunny" Balwani have pleaded not guilty to charges they defrauded investors, doctors and patients by falsely claiming Theranos could revolutionize medical lab testing with technology that could enable a wide array of tests with a few drops of blood.

© Reuters. FILE PHOTO: Former Theranos CEO Elizabeth Holmes arrives for a hearing at a federal court in San Jose

Before its unraveling, Theranos had been valued at $9 billion and made Holmes, a Stanford University dropout who founded the company in 2003 at age 19, a Silicon Valley star.

Holmes' trial is scheduled for March 2021. She and Balwani were originally indicted in June 2018. Balwani's case is being handled separately.

The case is U.S. v. Holmes, U.S. District Court, Northern District of California, No. 18-cr-00258.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.